skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report

Case report

(2417) Views  (638) Full article downloads

Authors: Carlos E Mendez, Robert J Tanenberg, Walter Pories

Published Date August 2010 Volume 2010:3 Pages 281 - 283
DOI: http://dx.doi.org/10.2147/DMSO.S9981

Carlos E Mendez, Robert J Tanenberg, Walter Pories

Diabetes and Obesity Institute, East Carolina University, Greenville, NC, USA

Abstract: Roux-en-Y gastric bypass surgery (RYGB) reverses type 2 diabetes (DM2) in approximately 83% of patients with morbid or severe obesity. This procedure has been performed in small numbers of severely obese patients with type 1 diabetes (DM1), but the impact on glycemic control and insulin requirement in this population has not been widely described. We report three patients with DM1 and severe obesity that underwent RYGB. Weight, glycemic control, and insulin requirements before and one year after the procedure were compared. Significant weight loss was achieved by all three patients but insulin requirements decreased in only 2 patients. In contrast, glycemic control (A1C) remained suboptimal in all three patients up to one year after the surgery. These findings suggest that RYGB leads to important weight loss and positively affects insulin sensitivity. However, reaching optimal glycemic control in patients with DM1 diabetes remains challenging due to persisting insulin deficiency.

Keywords: gastric bypass, Roux-en-Y, obesity, diabetes, insulin








Readers of this article also read:
  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio